As of 2024-10-04, the Relative Valuation of Ironwood Pharmaceuticals Inc (IRWD) is 2.87 USD. This relative valuation is based on P/E multiples. With the latest stock price at 4.23 USD, the upside of Ironwood Pharmaceuticals Inc based on Relative Valuation is -32.1%.
The range of the Relative Valuation is 1.76 - 4.03 USD.
| Range | Selected | |
| Trailing P/E multiples | 58.6x - 69.9x | 64.7x |
| Forward P/E multiples | 30.5x - 46.1x | 34.9x |
| Fair Price | 1.76 - 4.03 | 2.87 |
| Upside | -58.4% - -4.8% | -32.1% |
| Date | P/E |
| 2024-10-04 | 74.04 |
| 2024-10-03 | 73.35 |
| 2024-10-02 | 73.87 |
| 2024-10-01 | 69.71 |
| 2024-09-30 | 71.44 |
| 2024-09-27 | 69.71 |
| 2024-09-26 | 70.40 |
| 2024-09-25 | 68.15 |
| 2024-09-24 | 69.71 |
| 2024-09-23 | 70.75 |
| 2024-09-20 | 74.56 |
| 2024-09-19 | 78.21 |
| 2024-09-18 | 78.38 |
| 2024-09-17 | 77.69 |
| 2024-09-16 | 77.51 |
| 2024-09-13 | 79.25 |
| 2024-09-12 | 78.55 |
| 2024-09-11 | 75.43 |
| 2024-09-10 | 70.75 |
| 2024-09-09 | 69.01 |
| 2024-09-06 | 78.21 |
| 2024-09-05 | 80.81 |
| 2024-09-04 | 86.01 |
| 2024-09-03 | 86.36 |
| 2024-08-30 | 87.74 |
| 2024-08-29 | 88.61 |
| 2024-08-28 | 82.37 |
| 2024-08-27 | 84.97 |
| 2024-08-26 | 87.40 |
| 2024-08-23 | 86.36 |
| 2024-08-22 | 81.33 |
| 2024-08-21 | 86.70 |
| 2024-08-20 | 82.71 |
| 2024-08-19 | 82.54 |
| 2024-08-16 | 74.91 |
| 2024-08-15 | 77.16 |
| 2024-08-14 | 75.26 |
| 2024-08-13 | 77.86 |
| 2024-08-12 | 73.52 |
| 2024-08-09 | 73.52 |
| 2024-08-08 | 70.23 |
| 2024-08-07 | 104.22 |
| 2024-08-06 | 105.26 |
| 2024-08-05 | 107.51 |
| 2024-08-02 | 113.23 |
| 2024-08-01 | 114.27 |
| 2024-07-31 | 118.44 |
| 2024-07-30 | 120.34 |
| 2024-07-29 | 120.34 |
| 2024-07-26 | 122.08 |